Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells (Q37003558)
Jump to navigation
Jump to search
scientific article published on 04 September 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells |
scientific article published on 04 September 2008 |
Statements
1 reference
Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells (English)
1 reference
Guido Marcucci
1 reference
John C Byrd
1 reference
William Blum
1 reference
Natarajan Muthusamy
1 reference
Leslie Andritsos
1 reference
Gerard Lozanski
1 reference
Ching-Shih Chen
1 reference
Asha Ramanunni
1 reference
Rosa Lapalombella
1 reference
Amy Lehman
1 reference
Bo Yu
1 reference
Georgia Triantafillou
1 reference
Qing Liu
1 reference
Jonathan P Butchar
1 reference
Lisa L Smith
1 reference
Da-Sheng Wang
1 reference
Amy J Johnson
1 reference
Robert J Lee
1 reference
L James Lee
1 reference
Susheela Tridandapani
1 reference
4 September 2008
1 reference
1 reference
5180-5189
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference